Skip to content
Hanauer Landstrasse 287 · 60314 Frankfurt am Main

HomeTag: Ozempic Successors for Investors

Tag: Ozempic Successors for Investors

Ozempic Successors for Investors

Ozempic Patent Cliff: How Investors Can Profit from the GLP-1 Market After Patent Expiry

The GLP-1 market has fundamentally reshaped the pharmaceutical industry over the past five years. Ozempic by Novo Nordisk has emerged as a global blockbuster, generating billions in annual revenue and transforming the treatment landscape for type 2 diabetes and obesity. But as with every highly protected innovation,

Contact us or request a callback

+49 (0) 69 / 606 278 – 0 info@legal-patent.com Request a callback